Simulations Plus
SLP----
Simulations Plus (SLP)
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Simulations Plus Analyst Rating
View MoreForecast & Rating
Jul 10, 2026Price forecast
$17.25-5.89%
Forecast & RatingHold
5analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- prnewswire · 13 hours ago
13:41 ET$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG
- prnewswire · Jul 10 at 12:40 PM
13:38 ETSHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--PULM, SLP, OLN, and HUN
- benzinga_article · Jul 10 at 11:38 AM
Dow Gains 50 Points; Simulations Plus Earnings Top Views
- Market Beat · Jul 10 at 06:11 AM
Simulations Plus (NASDAQ:SLP) Releases FY 2026 Earnings Guidance
- rttnews · Jul 10 at 05:45 AM
Simulation Plus Q3 Returns To Profit, Revenues Rise
- benzinga_article · Jul 10 at 01:39 AM
Delta Air Lines, Netflix and 3 Stocks to Watch Heading Into Friday
